Related Experiment Videos
Matrix metalloproteinases in immunity
E J Goetzl1, M J Banda, D Leppert
1Department of Medicine, University of California, San Francisco 94143, USA.
Abstract:
Matrix metalloproteinases (MMPs) are a family of zinc-containing endo-proteinases that share structural domains but differ in substrate specificity, cellular sources, and inducibility. Macrophage production and secretion of large quantities of many MMPs, after contact with matrix proteins, is enhanced by surface determinants on activated T cells and suppressed by cytokines from Th1 and Th2 cells. T cells secrete predominantly the gelatinases MMP-2 and -9, after beta 1, integrin- or vascular cell adhesion molecule (VCAM)-1-dependent stimulation by cytokines and inflammatory mediators. MMPs of both T cells and macrophages facilitate secretion of TNF-alpha, by cleavage of the membrane-bound form. T cell MMPs prepare connective tissue matrices for T cell chemotaxis across basement membranes and through tissues. The greater amounts of diverse MMPs from macrophages are capable of degrading connective tissues, which may release stored growth factors. In limited studies of animal models of autoimmunity, specific MMP inhibitors have significantly decreased edema and inflammatory tissue damage, suggesting possible therapeutic benefits.
Insights
Matrix metalloproteinases (MMPs) are enzymes crucial in tissue remodeling. This study highlights their roles in immune responses and suggests MMP inhibitors may treat autoimmune diseases.
Area of Science:
- Immunology
- Biochemistry
- Cell Biology
Background:
- Matrix metalloproteinases (MMPs) are a diverse family of zinc-dependent endopeptidases.
- MMPs play roles in extracellular matrix degradation and tissue remodeling.
- Immune cells, including macrophages and T cells, produce and secrete various MMPs.
Purpose of the Study:
- To elucidate the specific roles of MMPs secreted by macrophages and T cells in immune responses.
- To investigate the regulation of MMP production by immune cell interactions and cytokines.
- To explore the potential therapeutic applications of MMP inhibitors in autoimmune diseases.
Main Methods:
- Analysis of MMP production and secretion by macrophages and T cells.
- Investigation of regulatory mechanisms involving cell surface molecules (e.g., integrins, VCAM-1) and cytokines.
- Evaluation of MMP activity in animal models of autoimmunity.
Main Results:
- T cells primarily secrete gelatinases (MMP-2, MMP-9) upon stimulation.
- Macrophage-derived MMPs contribute to connective tissue degradation and growth factor release.
- MMPs from both cell types facilitate TNF-alpha secretion.
- MMP inhibitors demonstrated therapeutic potential by reducing edema and inflammation in animal models.
Conclusions:
- MMPs are critical mediators in immune cell function, tissue remodeling, and inflammatory processes.
- Targeting MMPs with inhibitors shows promise for managing autoimmune conditions and associated tissue damage.